(Q54508706)

English

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised con

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised con (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

hypercholesterolemia

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Evan A Stein

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Dan Gipe

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Jean Bergeron

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Daniel Gaudet

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Robert Weiss

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Robert Dufour

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Richard Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Robert Pordy

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

language of work or name

0 references

publication date

26 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

380

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

9836

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

29-36

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Lipid-Lowering Treatment on Natural History of Heterozygous Familial Hypercholesterolemia in Past Three Decades

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the use of LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a monoclonal antibody to PCSK9 on LDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of LDL apheresis in patients with severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960771-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)60771-5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/22633824

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54508706&oldid=2042903398"